Scientific Department, Wellcomet GmbH, Karlsruhe, Germany.
Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX 75390-8549, USA.
Trends Endocrinol Metab. 2024 Sep;35(9):769-780. doi: 10.1016/j.tem.2024.04.004. Epub 2024 Apr 29.
Lipedema is a poorly understood disorder of adipose tissue characterized by abnormal but symmetrical deposition of subcutaneous white adipose tissue (WAT) in proximal extremities. Here, we propose that the underlying cause for lipedema could be triggered by a selective accumulation of bacterial lipopolysaccharides (LPS; also known as endotoxin) in gluteofemoral WAT. Together with a malfunctioning complement system, this induces low-grade inflammation in the depot and raises its uncontrollable expansion. Correspondingly, more attention should be paid in future research to the endotoxemia prevalent in patients with lipedema. We would like to propose that proper management of endotoxemia can reduce the progression and even improve the state of disease in patients with lipedema.
脂肪水肿是一种尚未完全被理解的脂肪组织疾病,其特征是近端肢体出现异常但对称的皮下白色脂肪组织(WAT)沉积。在这里,我们提出脂肪水肿的根本原因可能是由于臀部和股部 WAT 中细菌脂多糖(LPS;也称为内毒素)的选择性积累引发的。与功能失调的补体系统一起,这会在储存库中引起低度炎症,并导致其不可控的扩张。相应地,未来的研究应该更加关注脂肪水肿患者普遍存在的内毒素血症。我们建议适当控制内毒素血症可以减少脂肪水肿患者的病情进展,甚至改善其疾病状态。